BioSpace News Archive

Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today reported operating results for the second quarter of 2020.

--Expands AI/ML Capabilities and Gains Exclusive Rights to Leading Suite of Cheminformatics Technologies-- --Conifer Point’s Technologies Enable Expansion of Lodo’s P4 Platform™ to Include Therapeutic Target-Based De Novo Drug Discovery-- --Represents Major Advance in Lodo’s Reinvention of Natural Product Drug Discovery-- --Lodo to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference--

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman , Nevro’s Chairman, CEO and President, will present at the Canaccord Genuity 40 th Annual Virtual Growth Conference on August 13, 2020 , be

Sigilon Therapeutics, Inc., a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today announced that Chief Executive Officer, Rogerio Vivaldi, M.D., will participate in three upcoming virtual investor conferences. Presentation Details: Event: BTIG Virtual Biotechnology Conference Date: Monday, August 10, 2020 Time: 9

Cybin Corp. (“Cybin” or the “Company”), Canada’s leading-edge mushroom life sciences company, is proud to applaud the efforts of TheraPsil, a non-profit coalition that advocates for legal, Special Access Programme (SAP) access to psilocybin therapy for palliative care of Canadians.

Bruker Corporation (Nasdaq: BRKR) today announced a collaboration with Utrecht University to advance the study of the 3-D structures and interactions of proteins by mass spectrometry.

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that the company plans to present at the BTIG Biotechnology Conference 2020 (Virtual) on August 11, 2020 at 2:30pm ET. A live and archived webcast of the presentation will be available in the Investors section of the Iovance website at http://ir.iovance.com . About Iovance Biotherapeut

Aug. 7, 2020 11:15 UTC Newly Published Physician Fee Schedules for 0356T for the Administration of Intracanalicular Inserts to Support Ongoing DEXTENZA® Launch May Financing Yields $48.3 Million in Net Proceeds DEXTENZA Net Product Revenue in Second Quarter of $1.4 million; Billable In-Market Sales Record Achieved in June

Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Friday, August 14, 2020 at 8:30 a.m. ET to report financial results for the second quarter ended June 30, 2020 and to provide a business overview. To access the live con

Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that the Company intends to release its second quarter financial results on Wednesday, August 12, 2020. Management plans to host a conference call and live webcast at 4:30 p.m. ET on that day to discuss these results and